4.6 Article

Detection of Nipah and Hendra Viruses Using Recombinant Human Ephrin B2 Capture Virus in Immunoassays

Related references

Note: Only part of the references are listed.
Article Virology

Combining a Universal Capture Ligand and Pan-Serotype Monoclonal Antibody to Develop a Pan-Serotype Lateral Flow Strip Test for Foot-and-Mouth Disease Virus Detection

Ming Yang et al.

Summary: Foot-and-mouth disease virus (FMDV) is a highly contagious virus that causes a devastating disease in cloven-hoofed animals. We have developed a rapid lateral flow strip test (LFST) that can detect FMDV, which is comparable to current laboratory methods in terms of sensitivity and specificity. This LFST can be used for on-site detection in endemic countries with limited laboratory resources.

VIRUSES-BASEL (2022)

Article Virology

Inference of Nipah virus evolution, 1999-2015

Shannon L. M. Whitmer et al.

Summary: Using NiV-specific probes, 35 additional unique full-length genomic sequences were successfully generated from human specimens and viral isolates. The study inferred the evolutionary history of NiV in Bangladesh and demonstrated NiV's spatio-temporal spread in the country. Two distinct clades of NiV strains in Bangladesh were observed without significant genetic variation. Recommendations for future public health measures were also provided, including further research on genetic variation in the bat population and surveillance techniques for detecting NiV.

VIRUS EVOLUTION (2021)

Review Chemistry, Analytical

Ten Years of Lateral Flow Immunoassay Technique Applications: Trends, Challenges and Future Perspectives

Fabio Di Nardo et al.

Summary: LFIA is a successful analytical platform for on-site detection of target substances, with features like rapidity, simplicity, cost-effectiveness, and usability by nonskilled personnel. It is widely used in clinical diagnostic and other fields due to its wide acceptance. This review provides a 10-year overview of LFIA applications, discussing future perspectives and challenges.

SENSORS (2021)

Article Public, Environmental & Occupational Health

Hendra virus: Epidemiology dynamics in relation to climate change, diagnostic tests and control measures

Ka Y. Yuen et al.

Summary: Hendra virus (HeV) remains a serious public health concern, with symptoms including frothy nasal discharge and ataxia. The Equivac (R) HeV vaccine is the most effective preventive measure, protecting horses and humans from infection.

ONE HEALTH (2021)

Article Virology

Inference of Nipah virus evolution, 1999-2015

Shannon L. M. Whitmer et al.

Summary: This study successfully generated 35 unique full-length genomic sequences of Nipah virus from human specimens and viral isolates using targeted enrichment with custom probes. The research revealed the temporal and geographic evolutionary history of Nipah virus in Bangladesh.

VIRUS EVOLUTION (2021)

Review Virology

Emerging trends of Nipah virus: A review

Vikrant Sharma et al.

REVIEWS IN MEDICAL VIROLOGY (2019)

Article Biochemistry & Molecular Biology

An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections

Ha V. Dang et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)

Article Public, Environmental & Occupational Health

Diagnostics for Nipah virus: a zoonotic pathogen endemic to Southeast Asia

Laura T. Mazzola et al.

BMJ GLOBAL HEALTH (2019)

Article Multidisciplinary Sciences

Monomeric ephrinB2 binding induces allosteric changes in Nipah virus G that precede its full activation

Joyce J. W. Wong et al.

NATURE COMMUNICATIONS (2017)

Article Immunology

Hendra Virus Vaccine, a One Health Approach to Protecting Horse, Human, and Environmental Health

Deborah Middleton et al.

EMERGING INFECTIOUS DISEASES (2014)

Review Virology

Hendra and Nipah infection: Emerging paramyxoviruses

Mohamad Aljofan

VIRUS RESEARCH (2013)

Review Cell Biology

Ephrin-B2 and ephrin-B3 as functional henipavirus receptors

Kai Xu et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)

Review Virology

Henipavirus Mediated Membrane Fusion, Virus Entry and Targeted Therapeutics

Deborah L. Steffen et al.

VIRUSES-BASEL (2012)

Article Immunology

Genomic Characterization of Nipah Virus, West Bengal, India

Vidya A. Arankalle et al.

EMERGING INFECTIOUS DISEASES (2011)

Article Biochemistry & Molecular Biology

Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2

Thomas A. Bowden et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)

Article Biochemical Research Methods

Neutralization assays for differential henipavirus serology using Bio-Plex Protein Array Systems

Katharine N. Bossart et al.

JOURNAL OF VIROLOGICAL METHODS (2007)

Review Immunology

Recent progress in henipavirus research

Kim Halpin et al.

COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2007)

Article Virology

Recombinant nipah virus vaccines protect pigs against challenge

Hana M. Weingartl et al.

JOURNAL OF VIROLOGY (2006)

Article Biochemical Research Methods

Production and characterization of monoclonal antibodies against binary ethylenimine inactivated Nipah virus

Y Berhane et al.

JOURNAL OF VIROLOGICAL METHODS (2006)

Review Medicine, Research & Experimental

Hendra and Nipah viruses: Pathogenesis and therapeutics

BT Eaton et al.

CURRENT MOLECULAR MEDICINE (2005)

Article Multidisciplinary Sciences

Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus

MI Bonaparte et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Multidisciplinary Sciences

EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus

OA Negrete et al.

NATURE (2005)

Article Biochemical Research Methods

Utility of recombinant integrin αvβ6 as a capture reagent in immunoassays for the diagnosis of foot-and-mouth disease

NP Ferris et al.

JOURNAL OF VIROLOGICAL METHODS (2005)

Article Multidisciplinary Sciences

Nipah virus: A recently emergent deadly paramyxovirus

KB Chua et al.

SCIENCE (2000)